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Abstract
PM10 (the mass of particles present in the air having a 50% cutoff for particles with an
aerodynamic diameter of 10 mm) is the standard measure of particulate air pollution used
worldwide. Epidemiological studies suggest that asthma symptoms can be worsened by
increases in the levels of PM10. Epidemiological evidence at present indicates that PM10
increases do not raise the chances of initial sensitisation and induction of disease, although
further research is warranted. PM10 is a complex mixture of particle types and has many
components and there is no general agreement regarding which component(s) could lead to
exacerbations of asthma. However pro-inflammatory effects of transition metals, hydro-
carbons, ultrafine particles and endotoxin, all present to varying degrees in PM10, could be
important. An understanding of the role of the different components of PM10 in exacerbating
asthma is essential before proper risk assessment can be undertaken leading to advice on
risk management for the many asthmatics who are exposed to air pollution particles.
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Introduction
There has been a trend towards an increase in both
prevalence and exacerbations of asthma throughout the
late twentieth century, at a time when the issue of air
pollution has come to the fore in public and scientific
awareness. It is therefore reasonable to ask whether
there is a relationship between the two. Among the con-
stituents of the air pollution cocktail, the particles or
PM10 component is considered to be a significant culprit
in terms of mediating adverse health effects [1]. This
commentary focuses on the relationship between partic-
ulate air pollution and asthma.
PM10
The average UK city has 20–25 mg/m3 PM10 in the air, but
excursions to higher levels occur regularly [2]. The PM10
convention describes the mass of particles per unit air
volume that deposit in the upper and lower airspaces, but
excludes those that are so large that they deposit only in
the nasopharynx.
Trends in asthma occurrence and in particulate
air pollution
This topic has been dealt with in detail in a monograph by
the UK Committee on the Medical Effects of Air Pollutionhttp://respiratory-research.com/content/1/1/012
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[3]. There has been an increase in asthma, as measured
by wheeze, GP consultations or hospital admissions,
throughout the 1960s and up to the end of the 1990s. At
the same time air quality has improved because of stricter
control on industrial and domestic emissions ([3]; see also
http://aeat.co.uk/netcen/airqual/ for an excellent summary
of the UK experience of air pollution in the past 10 years).
However, despite the overall decrease in total mass of air-
borne particulates, the number of vehicles in the UK has
increased twofold to threefold over the past 25 years, and
concentrations of very small, combustion-derived particles
have actually risen during this period [4].
The relationship between PM10 and asthma
Asthma is a form of allergic lung disease that features an
accumulation of inflammatory cells and mucus in the
airways, with bronchoconstriction and a generalised
airflow limitation. The induction phase of the disease
arises from interactions between allergenic proteins and
immune cells. Subsequent exposure to allergens then
results in a complex cascade of mediators, which produce
airway narrowing and inflammation. In addition to having a
heightened sensitivity to allergens, asthmatics also
develop non-specific hyper-responsiveness to a wide
variety of stimuli including cigarette smoke, sulphur
dioxide, hypertonic saline and cold air. Many studies have
demonstrated that acute increases in PM10 result in a
greater use of asthma medication, more consultations of
GPs and increased hospital admissions for asthma [5–9].
Such data are typically expressed as the percentage
increase in, for example, asthma symptoms per 10 mg/m3
increase in PM10. A recent review [10] describes an
average 2% increase in hospitalisations and related health
care visits, and an approximate 3% increase in asthma
symptoms for each 10 mg/m3 rise in PM10 as the average
across a number of studies. In clinical studies, normal and
ragweed-sensitive human volunteers exposed to diesel
exhaust via the nose produced more allergic IgE antibody
[11]. However, there are studies that show a much less
clear picture of the association between PM10 and symp-
toms [12].
In contrast with the association between levels of air pollu-
tion and exacerbations of symptoms in asthmatic individu-
als seen in many (but not all) studies, the role of air
pollutants in the development of disease is controversial.
The large six-city study in the USA found no association
between the incidence of asthma and the level of airborne
particulates [1]. Comparative studies between East and
West Germany showed that the point prevalence of
asthma was higher in West Germany, whereas industrial
air pollution and levels of bronchitis were higher in East
Germany [13]. Finally, asthma rates have also risen in
other areas of the world (eg New Zealand) where there
are far lower levels of air pollution than the USA and
Europe.
Although this last point illustrates that the increasing inci-
dence of asthma is not dependent on ambient air quality,
the effect of exposure to air pollutants on allergic sensitisa-
tion has not been categorically ruled out. Several studies in
Europe and Japan have reported an increased frequency of
allergic sensitisation in individuals living in urban areas or
close to highways and therefore exposed to higher concen-
trations of vehicle exhaust [14]. In addition, a more recent
analysis of respiratory allergies between polluted and
‘clean’ counties in East Germany has found a strong asso-
ciation between sensitisation rates and amounts of air pol-
lution [15]. Finally, the fact that children exposed to
second-hand smoke have a doubled risk of developing
asthma [16] suggests that insult to the respiratory tract
might promote allergic sensitisation.
The toxicology paradigm as it applies to PM10
effects
The central paradigm of toxicology is exposure ® dose ®
response. We shall discuss these in turn in relation to
PM10 as the dose, and asthma as the response.
PM10 is not a single entity but represents all particulate
matter collected by the sampler from its immediate sur-
roundings at the sampling site. Therefore PM10 from a
rural site is largely windborne crustal material, while that
from a city centre would largely comprise vehicle-derived
particulates such as diesel soot. When site-specific vari-
ability is superimposed on seasonal, climatological and
global location it becomes clear that PM10 is a heteroge-
neous mixture of particle types. However, toxicologists
have identified several components of PM10 such as tran-
sition metals [17], ultrafine particles [18] aromatic hydro-
carbons [11] and endotoxin [20] that may be important in
driving the adverse effects.
The normal PM10 in the UK is around 25 mg/m3 of air. This
is a very low concentration of airborne particulate com-
pared with occupational settings such as mining and
some agricultural practices, in which the exposure can be
up to 4000 mg/m3 respirable dust. The association of
adverse health effects with such low ambient exposures is
thought to be due to the susceptible nature of the popula-
tions that are affected by PM10 such as asthmatics [10]. It
is also becoming clear that the mass of PM10 might not be
the best metric for describing the harmful fraction of air-
borne particle. The total mass is usually dominated by
larger secondary particles such as sulphates and nitrates,
which are generally considered to be of low toxicity,
whereas the mass contribution of metals, organics, ultra-
fine particles or endotoxin is much less.
Dose
Effective dose is the concentration of a substance that
mediates adverse effects and is of fundamental impor-
tance with a heterogeneous material such as PM10 for theRespiratory Research    Vol 1 No 1 Donaldson et al
successful performance of a risk assessment. In the case
of an endpoint such as an asthma attack, the effective
dose is likely to be the dose of particles that causes cells
to release substances such as pro-inflammatory and
immunoregulatory cytokines, lipid mediators, enzymes and
reactive oxygen species, which enhance immune and
inflammatory responses. Alternatively, in conjunction with
exposure to allergens, the effective dose could be the
concentration of particles that allows increased interaction
between antigen and immune cells, as would occur via
changes in epithelial permeability or by eliciting greater
numbers or activities of immunocompetent cells.
Air pollution particles can be divided roughly into those
that are formed immediately by combustion sources such
as diesel exhaust, which are carbon-centred, relatively
small in primary particle size and essentially insoluble.
Another principal type of particle is those created via
chemical reactions in the atmosphere, which arise as con-
densation nuclei containing the familiar soluble compo-
nents of PM10 such as sulphate and nitrates [2] and which
can grow according to climatic conditions. The carbon-
centred primary particles are considered to be most
potent in terms of their ability to cause lung injury. They
could be important for at least two reasons: first, they can
contain surface transition metals that can redox cycle in
the lung and generate harmful oxidants [17], and second,
they are in the ultrafine size range (less than 100 nm in
diameter), a size range that has been shown in numerous
toxicological studies to have enhanced toxicity [19].
The common pathway of oxidative stress is another poten-
tial harmful dose, although one that has to be considered
as different from the inherent properties of the particles
such as size or composition. Oxidative stress can be seen
as a function of the both the particle and the lung milieu.
The particle might contribute transition metals, whereas
the lung milieu supplies reducing activity in the form of
such molecules as glutathione and ascorbic acid, which
allow the transition metals to redox cycle. The antioxidant
defences of the lung will tend to protect against the oxida-
tive stress. Ultrafine particles might have their effects via
oxidative stress that arises from their large surface area
and particle number per unit mass, interacting with ele-
ments of the lung milieu.
Responses
Asthma is a complex disease whose symptoms include
wheezing, chest tightness and recurrent cough. Other
markers of the disease include the presence of IgE in aller-
gic asthmatics, increased numbers of eosinophils in blood
and tissue, and hypersecretion of mucus. Although many
of these features can be aggravated by pollutant expo-
sure, the complex nature of the asthmatic response and
the huge array of mediators that contribute to airway
disease precludes identifying one single mechanism for
pollutant-enhanced illness. Rather, several different path-
ways have been proposed that contribute to the asthmatic
response and which could be amplified by PM exposure.
These include the ability to cause inflammation with sub-
sequent tissue damage, increased translocation of antigen
to immune cells with subsequent increases in immune-
mediated disease, neurogenic stimulation with increased
smooth muscle constriction and airway inflammation, and
direct stimulation of lipid mediators and mucus, which
contribute to airway narrowing and blockage respectively.
The role of oxidative stress
The pathways arising from oxidative stress are known to
be important in asthma [21] and in inflammation in general,
and the redox-sensitive transcription factors NF-kB and
activator protein-1 (AP-1) are important in controlling the
expression of pro-inflammatory mediators [22]. We have
reported that oxidative stress can be detected systemi-
cally in asthmatics and that it worsens during an asthma
attacks [23]. PM10 is known to generate free radicals via
transition metal mechanisms [24] and has been reported
to cause oxidative stress in rats after pulmonary instillation
[25]. Additionally, cells treated with PM10 in vitro show
activation of NF-kB and AP-1 by pathways that involve the
generation of hydroxyl radicals by Fenton-type chemistry
[26]. The imposition of an additional oxidative, pro-inflam-
matory burden on the airway mucosa by depositing PM10
during a period of increased particulate air pollution could
therefore be important in triggering an asthmatic attack.
Conclusion
PM10 is the particulate component of air pollution that can
enter the lungs, deposit in the airways and also penetrate to
the periphery of the lungs. There is good epidemiological
evidence that asthma symptoms can be worsened by
increases in PM10 but less evidence at present that PM10
increases the likelihood of initial sensitisation and induction
of disease, although this matter requires further study.
Although PM10 is a complex mixture of substances, toxico-
logical studies have identified a number of components that
could render the dose of PM10 effective in enhancing inflam-
mation and causing oxidative stress. These include transi-
tion metals, hydrocarbons, ultrafine particles and endotoxin.
A clear understanding of the effective dose of PM10 that can
trigger or exacerbate asthma attacks is essential before
proper risk assessment can be undertaken. This will provide
much-needed advice directed at risk management for the
increasing numbers of asthmatics who are potentially
exposed. Well designed toxicological studies will provide a
better understanding of the constituents and concentrations
that make PM10 a hazard to asthmatics.
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